KRT88P and cervical carcinoma: In a study involving 277 cervical cancer patients, the seropositivity rates for HBsAg, HBeAg, and anti-HBc were found to be 4.33, 0.72, and 13.00%, respectively, indicating a potential relationship between HBV infection and cervical cancer (Wu et al., 2021).